Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of NFκB via suppression of GSK-3β expression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of NFκB via suppression of GSK-3β expression

Published:2011-08-15 Issue:4 Volume:12 Page:288-296
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Ban Jung Ok,Oh Ju Hoon,Son Seung Mo,Won Dohee,Song Ho Seub,Han Sang Bae,Moon Dong Cheul,Kang Keon Wook,Song Min Jong,Hong Jin Tae

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.4161/cbt.12.4.15961

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peroxisome proliferator-activated receptors: Key regulators of tumor progression and growth;Translational Oncology;2024-09

2. Anticancer drugs that modulate hormone action;Medicinal Chemistry of Anticancer Drugs;2023

3. Glycogen Synthase Kinase 3β: A True Foe in Pancreatic Cancer;International Journal of Molecular Sciences;2022-11-16

4. Metformin regulates multiple signaling pathways within castration-resistant human prostate cancer cells;BMC Cancer;2022-09-29

5. CD73 induces gemcitabine resistance in pancreatic ductal adenocarcinoma: A promising target with non-canonical mechanisms;Cancer Letters;2021-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP